when to inject retatrutide Weight Loss Retatrutide Weight Loss Treatment in

A Phase 2 trial published in the New England Journal of Medicine (2023) reported significant weight reduction with retatrutide over 48 weeks, and further trials are registered on ClinicalTrials

Still, outcomes can vary depending on dose, duration, baseline weight, health status, lifestyle factors, and individual biology

Animal studies have shown potential fetal risks, making pregnancy avoidance during treatment essential

N Engl J Med 1992;326:131622.PubMed 6

These results position injectable weight-loss meds like these as some of the most effective non-surgical treatments available today

Phase 2 Trials The findings of phase 1 studies supported the continued clinical development of retatrutide as a promising candidate for the treatment of obesity and T2D